English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [3057]
News [6188]
Articles [123]
Editorials [18]
Conferences [183]
elearning [32]
Loss of a DNA repair system creates a unique vulnerability in many cancer types
Loss of a DNA repair system creates a unique vulnerability in many cancer types
ELCC 2019: Maintenance immunotherapy fails to improve survival in extensive small cell lung cancer
ELCC 2019: Maintenance immunotherapy fails to improve survival in extensive small cell lung cancer
Releasing an immune system brake could help patients with rare but fatal brain infection
Releasing an immune system brake could help patients with rare but fatal brain infection
ELCC 2019: Studies give new insights on immunotherapy in elderly patients with advanced NSCLC
ELCC 2019: Studies give new insights on immunotherapy in elderly patients with advanced NSCLC
Cancer-killing combination therapies unveiled with new drug-screening tool
Cancer-killing combination therapies unveiled with new drug-screening tool
ESMO drives EU-level action to tackle shortages of essential medicines
ESMO drives EU-level action to tackle shortages of essential medicines
High-dose vitamin D shows benefit in patients with advanced colorectal cancer
High-dose vitamin D shows benefit in patients with advanced colorectal cancer
NICE makes first immunotherapy combination immediately available in advanced kidney cancer
NICE makes first immunotherapy combination immediately available in advanced kidney cancer
FDA approves palbociclib for male patients with HR-positive/HER2-negative breast cancer
FDA approves palbociclib for male patients with HR-positive/HER2-negative breast cancer
Experimental therapy completely clears HPV in one-third of cervical cancer precursors
Experimental therapy completely clears HPV in one-third of cervical cancer precursors
<1...310311312313314...619>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top